Treatment of Follicular Non-Hodgkin's Lymphoma: The Old and the New
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference35 articles.
1. Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas;Fisher;J Clin Oncol,2005
2. The Follicular Lymphoma International Prognostic Index (FLIPI) Is superior to WHO/REAL histological grade for identifying high-risk patients: A retrospective review of the MSKCC experience in 260 patients with follicular lymphoma;Halaas;Blood,2004
3. Follicular lymphoma international prognostic index;Solal-Celigny;Blood,2004
4. The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome
5. Prospective validation of the FLIPI: Baseline distribution and correlates in newly diagnosed follicular lymphoma (FL) patients from the US: First report of the National Lympho-Care Study;Link;Blood,2005
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current use of monoclonal antibodies in the treatment of multiple myeloma;British Journal of Haematology;2018-04-25
2. Coping with non-Hodgkin’s lymphoma: a qualitative study of patient perceptions and supportive care needs whilst undergoing chemotherapy;Supportive Care in Cancer;2017-02-23
3. Follicular lymphoma: 2015 update on diagnosis and management;American Journal of Hematology;2015-11-23
4. Lymphoma Immunotherapy: Current Status;Frontiers in Immunology;2015-09-01
5. Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2015-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3